Sensus Healthcare, Inc. (SRTS)

4.76 +0.33 (+7.45%) USD  |  NASDAQ  |  Jan 09, 16:00
4.81 +0.05 (+1.05%) After-Hours: 20:00
More

Sensus Healthcare Research and Development Expense (Annual): 4.216M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for SRTS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Xtant Medical Holdings, Inc. 2.385M
Perspective Therapeutics, Inc. 39.33M
InfuSystem Holdings, Inc. --
VolitionRX Ltd. 13.32M
Catheter Precision, Inc. 0.272M